EPIVAL
BGP PHARMA ULC
Quick answers
Is there a shortage of EPIVAL in Canada?
No. There is no current shortage of EPIVAL 250MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
Other Products
DOM-DIVALPROEX
DOMINION PHARMACAL
EPIVAL
BGP PHARMA ULC
APO-DIVALPROEX
APOTEX INC
PMS-DIVALPROEX (500MG)
PHARMASCIENCE INC
MYL-DIVALPROEX
MYLAN PHARMACEUTICALS ULC
DIN
00596426
Strength
250MG
Dosage Form
Tablet (Delayed-Release)
Route
Oral
Active Ingredient
VALPROIC ACID (DIVALPROEX SODIUM)
See all VALPROIC ACID (DIVALPROEX SODIUM) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from BGP PHARMA ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.